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Cytoplasmic flows localize injected oskar RNA in Drosophila
oocytes
Jolanta B. Glotzer, Rainer Saffrich, Michael Glotzer and Anne Ephrussi
Background: The oskar (osk) gene encodes a determinant of posterior identity in
Drosophila, and the localization of osk RNA to the pole plasm at the posterior pole
of the oocyte is essential for development of the embryo. The mechanisms by
which osk RNA is localized are unknown.
Results: To study the mechanisms underlying localization of osk RNA, we have
injected fluorescently labelled RNA into oocytes at stages 9, 10 and 11. Injected
osk RNA localizes to the pole plasm, reproducing localization of the endogenous
RNA. In oocytes at stages 10 and 11, the long-range movement of injected osk
RNA is promoted by a vigorous, microtubule-dependent cytoplasmic flow, or
ooplasmic streaming. Treatment with colchicine, a microtubule-destabilizing
drug, inhibits ooplasmic streaming and prevents localization of the RNA from an
injection site distal to the posterior pole. If the RNA is injected close to the
posterior pole, however, it localizes even in the presence of colchicine. Similarly,
in small oocytes, such as stage 9 oocytes, localization of injected osk RNA is
insensitive to colchicine. 
Conclusions: These results reveal that microtubule-dependent cytoplasmic
flows could contribute to the long-range transport of osk RNA, whereas
microtubule-independent processes could mediate short-range transport. These
results also highlight the role of the osk RNA anchor in the localization process.
Background
Messenger RNAs are localized to precise cytoplasmic
locations in a wide variety of cell types, allowing spatial
control of the distribution of the encoded protein products
(reviewed in [1–4]). The localization of oskar (osk) RNA to
the posterior pole of the Drosophila oocyte is essential for
proper development of the embryo. Failure to localize osk
RNA during oogenesis results in embryos lacking an
abdomen and a germ line [5,6]. Conversely, ectopic
localization of osk RNA causes embryos to form an ectopic
abdomen and germ cells, and is lethal [5,7]. Localization
of osk RNA to the posterior pole of the oocyte establishes
a localized source of OSK protein [8–10], inducing
assembly of the germ plasm, or pole plasm.
The Drosophila oocyte develops in an egg chamber
consisting of a syncytium of 15 nurse cells and an oocyte,
enveloped in a monolayer of follicle cells. The nurse cells
are connected to each other and to the oocyte at its anterior
by ring canals, allowing the intercellular flow of molecules
and organelles (reviewed in [11]). Development of the
oocyte takes 80 hours and has been divided into 14 mor-
phologically distinct stages (for a review of oogenesis, see
[12]). The synthesis of osk RNA occurs in the nurse cells,
and the RNA accumulates in the oocyte during stages 1–7.
At stages 8/9, osk RNA is transiently enriched at the
anterior of the oocyte and begins to accumulate at the
posterior pole, where it persists throughout oogenesis and
early embryogenesis [5,6]. The localization of osk RNA
therefore occurs in at least two phases: first, the RNA is
transported from the nurse cells into the oocyte, then it is
transported within the oocyte to the posterior pole.
Localization of osk RNA appears to involve the
cytoskeleton. Early in oogenesis, when osk RNA accumu-
lates uniformly throughout the oocyte, microtubules
extend from the oocyte through the ring canals into the
nurse cells [13]. During mid-oogenesis, before osk RNA
begins to accumulate at the posterior pole of the oocyte,
the majority of microtubules within the oocyte form a
polarized anteroposterior gradient. Depolymerization of
the microtubules abolishes osk RNA accumulation in
oocytes at stages 1–7 and prevents its posterior localization
in oocytes at stages 8/9 [14–16], suggesting that micro-
tubules participate in both phases of osk RNA localization.
Actin filaments may also be involved in the second phase
of osk RNA localization, as mutations in an actin-binding
protein, tropomyosin II (TmII), inhibit osk RNA accumu-
lation at the posterior pole of the oocyte, but not its initial
localization to the oocyte [17,18].
The mechanisms underlying osk RNA localization are
unknown. The RNA might be localized by motor-
dependent directional transport along the cytoskeletal
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elements. Alternatively, the RNA might be transported
by the bulk cytoplasmic flows generated by motor-depen-
dent transport of organelles along the cytoskeletal ele-
ments. The RNA could then be concentrated by binding
to a localized anchor. To study how osk RNA is localized
to the posterior pole of the oocyte, we have developed an
assay in which fluorescently labelled RNA is injected into
live oocytes and the movement of the RNA is observed
during the process of localization. We observed that
injected osk RNA first disperses throughout the ooplasm,
then accumulates at the posterior pole. The dispersion of
the injected RNA is promoted by microtubule-dependent
cytoplasmic flows, indicating that such flows might con-
tribute to the localization of endogenous osk RNA during
Drosophila oogenesis.
Results
Fluorescently labelled osk RNA localizes to the posterior
pole of stage 9, 10 and 11 oocytes
To study how osk RNA is localized within the oocyte, we
injected fluorescently labelled RNA into dissected, live,
wild-type oocytes at different stages. Oocytes at stage 9, in
which endogenous osk RNA is localized to both the ante-
rior and the posterior poles, were injected in the center,
and oocytes at stages 10 and 11, in which endogenous osk
RNA is localized to the posterior pole, were injected at the
anterior. The injected oocytes were cultured in vitro and
observed by fluorescence microscopy.
Oocytes were injected with either full-length osk RNA or
with the 3′ untranslated region (UTR) alone (Fig. 1b,d);
the osk 3′ UTR is sufficient to direct posterior localization 
of a reporter RNA [19]. Both injected osk RNAs 
accumulated specifically at the posterior pole of oocytes at
stages 10 and 11 (Fig. 1c,e,g). In oocytes at stage 9,
injected osk RNA accumulated at both the anterior and the
posterior poles (Fig. 1f). Posterior accumulation of injected
osk RNA was first detected approximately 1.5 hours after
injection. Over the next 1–2 hours, we observed an increas-
ing number of oocytes with localized RNA; after this time,
the morphology of oocytes, particularly young oocytes,
began to deteriorate. We therefore limited the analysis of
the fate of injected RNA to 2–3 hours after injection. At all
stages, the distribution of the injected RNA closely resem-
bled that of endogenous osk RNA (compare to Fig. 1a). In
all oocytes, nonlocalized RNA was dispersed uniformly
throughout the ooplasm, with residual amounts of the
RNA remaining near the site of injection. A minor amount
of RNA was occasionally detected in the nurse cells,
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Figure 1
Injected osk RNA localizes to the posterior pole in oocytes at stages 9,
10 and 11 and its distribution resembles that of endogenous osk RNA.
(a) Distribution of endogenous osk RNA in Drosophila egg chambers
as detected by fluorescent in situ hybridization. During stages 1–7, osk
RNA accumulates in the oocyte; at stages 8/9 it is transiently enriched
at the oocyte anterior and begins to accumulate at the posterior pole,
where it persists until the end of oogenesis. (b–e) Distribution of
injected, fluorescently labelled osk RNA (3′ UTR) in oocytes at stage
10. (b,d) Two egg chambers are shown, by a combination of phase
contrast and epifluorescent images, immediately after injection at the
anterior of the oocyte (arrow indicates injection site). (c,e)
Subsequently, a fraction of osk RNA localizes to the posterior pole of
the two oocytes. (f,g) osk RNA (3′ UTR) localizes to the anterior and
the posterior poles of the oocyte at stage 9 injected in the center (f) and
to the posterior pole of the oocyte at stage 11 injected at the anterior
(g). (h,i) Two different oocytes showing that, at the posterior pole, both
endogenous osk RNA (h) and injected osk RNA (i) are organized in
particles. Except for (b,d), all images are confocal micrographs and the
images of injected oocytes were acquired 1.5–3 h after injection. All
oocytes are shown with the posterior pole on the right. Scale bars:
100 mm in (a–g) and 10 mm in (h,i).
indicating that translocation of the RNA from the oocyte
into the nurse cells was minimal.
Further analysis of the distribution of injected osk RNA at
high magnification revealed that the RNA that had accu-
mulated at the posterior pole was organized in particles of
less than 1 mm diameter (Fig. 1i). This particulate distribu-
tion was similar to that of endogenous osk RNA (Fig. 1h).
Such particles were seldom observed elsewhere in the
ooplasm, with the exception of the injection site, suggest-
ing that particle assembly occurs where RNA concentration
is high. To determine whether individual particles con-
sisted of several RNA molecules, we coinjected rhodamine-
and fluorescein-labelled osk RNAs. Most fluorescent parti-
cles contained both fluorochromes, and intensity measure-
ments indicated that an average particle contained more
than 100 osk RNA molecules (data not shown).
The similarity in distribution of injected osk RNA to that
of endogenous osk RNA, at the anterior and the posterior
poles of stage 9 oocytes, at the posterior pole of stage 10
and 11 oocytes, and in particles, suggests that our injection
assay reproduces the localization of endogenous osk RNA
in the Drosophila oocyte.
Injected osk RNA accumulates in the pole plasm
Early observations defined pole plasm as the yolk-free
region at the posterior pole of the Drosophila early
embryo [20]. To determine whether injected osk RNA
localized to the pole plasm, we compared the distribution
of injected RNA with that of the autofluorescent yolk
platelets; injected osk RNA was enriched specifically in
the yolk-free region at the posterior pole of the oocyte
(Fig. 2a). The distribution of injected osk RNA was also
compared to that of a molecular marker of the pole
plasm, Vasa (VAS) protein [21]; we visualized VAS using
GFP–VAS, a protein fusion of VAS and the green fluo-
rescent protein (GFP) of Aequorea victoria [22,23]. When
egg chambers expressing GFP–VAS were injected with
osk RNA, both molecules were enriched at the posterior
pole and were organized in particles of similar size (Fig.
2b). Some particles contained both osk RNA and
GFP–VAS. At the posterior pole, injected osk RNA also
colocalized with other pole-plasm components, Staufen
(Stau) [24] and OSK proteins, as visualized by immuno-
fluorescence of injected oocytes (data not shown). These
results indicate that injected osk RNA localizes to the
pole plasm. In addition, as the pole plasm is juxtaposed
to the oocyte cortex, which contains both actin filaments
and microtubules [13,25], we found that injected osk
RNA accumulated in the region adjacent to the actin-
rich cortex (Fig. 2c).
Accumulation in the pole plasm is specific to osk RNA
To establish that localization to the pole plasm was
specific to osk RNA, we analyzed the behaviour of
injected RNAs unrelated to osk, and mutant osk RNAs.
These RNAs were labelled with a fluorochrome different
from that marking the osk 3′ UTR, so that they could be
coinjected and their distributions compared.
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Figure 2
Injected osk RNA accumulates in the pole
plasm. Oocytes were injected with rhodamine-
labelled (a,b) or fluorescein-labelled (c) osk
RNA (3′ UTR) at the anterior, and the
distributions of the RNA and other markers
were analyzed by confocal microscopy. (a)
Injected osk RNA accumulates at the
posterior pole of the oocyte in the yolk-free
pole plasm. (b) Injected osk RNA and
GFP–VAS colocalize to the pole plasm and
form similar-sized particles, some of which
contain both osk RNA and GFP–VAS. (c)
Injected osk RNA localizes in the region
adjacent to the actin-rich oocyte cortex
(arrow; arrowhead indicates the actin-rich
cortex of neighbouring follicle cells).
Filamentous actin is detected with rhodamine-
labelled phalloidin. Scale bars: 100 mm;
10 mm in images at high magnification.
Yolk platelets(a) osk RNA Overlay
GFP–VAS(b) osk RNA Overlay High magnification
Actin(c) osk RNA Overlay High magnification
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First, we asked how RNAs that lack localization signals
are distributed when injected into the oocyte. Endoge-
nous ribosomal protein 49 (rp49) RNA is distributed uni-
formly in oocytes throughout oogenesis [26]. When rp49
and osk RNAs were coinjected, rp49 RNA dispersed uni-
formly throughout the oocyte and failed to accumulate at
the posterior pole, whereas osk RNA localized to the pos-
terior pole (Fig. 3a). Similar results were observed when
other nonlocalized RNAs were coinjected with osk RNA
(Fig. 3c), indicating that pole-plasm localization is specific
to osk RNA.
Second, we examined the fate of injected bicoid (bcd)
RNA [27,28]. As the 3′ UTR of bcd RNA contains the
signals for its anterior localization [29], we coinjected it
with osk RNA in the center of the oocyte. Initially, both
RNAs dispersed throughout the ooplasm. However,
approximately 2 hours after injection, bcd RNA was found
associated with most of the oocyte cortex, whereas osk
RNA was enriched in the pole plasm (Fig. 3b). The local-
ization of bcd RNA to the cortex and its absence from the
pole plasm further demonstrate that the localization of
injected osk RNA is specific, and that the targets of the
localization are distinct for these two RNAs.
Finally, we examined the sequences in osk RNA that
were required for its localization in our injection assay
(Fig. 3d). When the osk RNA coding region alone was
injected, it dispersed throughout the ooplasm and failed
to accumulate at the posterior pole. Fragments of the osk
3′ UTR displayed patterns of localization consistent with
those reported for the corresponding fragments analyzed
in transgenic animals [19,30].
As all the injected RNAs were initially observed to be
distributed throughout the ooplasm, dispersion of the
RNA appears not to depend on specific RNA sequences.
However, localization of injected RNA to the pole plasm
requires osk RNA posterior localization signals.
Mutations that prevent localization of endogenous osk
RNA prevent localization of injected osk RNA
We further examined the fate of injected osk RNA in
oocytes dissected from mutants in which endogenous osk
RNA fails to localize to the posterior pole (Table 1). In
cappuccino (capu) and spire (spir) [31] mutant egg chambers,
endogenous osk RNA is not localized [5,6]. When osk RNA
was injected into capu and spir oocytes at stages 10 and 11,
it did not localize to the posterior pole. In TmII and stau
mutant egg chambers, endogenous osk RNA shows
enhanced accumulation at the anterior of oocytes at stages
8/9 and fails to localize to the posterior pole [5,6,17]. When
osk RNA was injected into TmII oocytes at stage 9, it was
frequently enriched at the anterior and never localized to
Figure 3
Accumulation in the pole plasm is specific to
osk RNA. Oocytes were coinjected with osk
and other RNAs labelled with different
fluorochromes. (a) Fluorescein-labelled rp49
RNA injected at the oocyte anterior disperses
uniformly within the ooplasm, whereas
coinjected rhodamine-labelled osk RNA 
(3′ UTR) localizes to the pole plasm. No
colocalization of rp49 RNA and osk RNA is
observed in the pole plasm. Residual amounts
of both RNAs remain near the injection site
(arrow). (b) Rhodamine-labelled bcd RNA 
(3′ UTR) injected in the center of the oocyte
localizes to the oocyte cortex, whereas
coinjected fluorescein-labelled osk RNA 
(3′ UTR) localizes to the pole plasm. No
colocalization of bcd RNA and osk RNA is
observed in the pole plasm. Residual amounts
of both RNAs remain near the injection site
(arrow). (c) Summary of localization of injected
RNAs: rp49, bcd, cyclinB-b-globin, and plasmid
sequences (pBluescriptII) fail to localize to the
pole plasm, whereas the coinjected osk RNA
localizes. (d) Deletion analysis of the osk
posterior localization signal. The full-length osk
RNA and the 3′ UTR of osk RNA, but not the
coding region alone, have been shown to
localize reporter sequences in transgenic
animals [19]. An osk 3′ UTR fragment 3′ to DraI
site, has been reported to localize some reporter
sequences [30] but not others [19]. Although
the Sty I–DraI fragment of the osk 3′ UTR alone
has not been tested in transgenic animals, it can
be deduced from other constructs that it would
most likely fail to localize (see olc29 construct in
[19]). Scale bars: 100 mm.
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the posterior pole. In neither TmII nor stau oocytes at
stages 10 and 11 did the injected osk RNA localize to the
posterior pole. These results indicate that spir, capu, TmII
and stau functions are required for the correct posterior
localization of both endogenous and injected osk RNAs.
In osk mutant egg chambers, including osk54, in which
OSK protein is not produced [9,10], endogenous osk RNA
is localized to the posterior pole of oocytes at stages 8/9
[5,6]. During the later stages of oogenesis, endogenous
osk RNA becomes delocalized and dispersed in the
ooplasm, indicating that OSK protein plays a role in the
maintenance of osk RNA localized during stages 8/9. We
injected osk RNA into osk54 mutant oocytes at stages 9, 10
and 11, and found that the RNA did not localize, indicat-
ing that OSK protein is required for the localization of
injected osk RNA.
Injected osk RNA accumulates at the posterior pole as
ooplasmic streaming proceeds
To observe directly how fluorescently labelled osk RNA
localizes to the posterior pole, movement of the RNA was
recorded by digital microscopy. We focused on document-
ing the localization process in oocytes at stage 10b, as
younger oocytes are very fragile and difficult to handle.
The ooplasm of stage 10b–12 oocytes moves vigorously;
this cytoplasmic flow or ooplasmic streaming is easily visu-
alized as the autofluorescent yolk platelets move in con-
centric circular waves at rates averaging 25 mm min–1
[32–34]. When stage 10b oocytes were injected with osk
RNA, we observed that, shortly after injection, a wave of
fluorescent RNA formed and spread circularly within the
ooplasm (data not shown). The RNA gradually filled the
entire ooplasm and began to accumulate at the posterior
pole (Fig. 4a and see Supplementary material for a video
clip). When paired images of the movements of the
injected RNA and of the autofluorescent yolk platelets
were compared, it could be seen that the wave of RNA
and the yolk platelets followed the same trajectory and
moved at similar rates — indicative of ooplasmic stream-
ing. The similarity of the path and the rate of movement
of the fluorescent RNA and the yolk platelets suggests
that the same mechanism mediates both movements.
We quantitated the posterior accumulation of the injected
osk RNA in oocytes that exhibited ooplasmic streaming.
Oocytes were selected that showed trace amounts of
fluorescent osk RNA localized to the posterior, and time-
lapse microscopy was used to record the subsequent local-
ization process (Fig. 4a). Quantitation of the accumulation
of fluorescent RNA at the posterior pole showed that the
amount of RNA increased over time both in the pole
plasm and in the neighbouring ooplasm (Fig. 4b). From
these data, we plotted the difference between the average
intensity of fluorescence in the pole plasm and that of the
neighbouring ooplasm. This revealed that, during the first
500 seconds of the analysis, the RNA accumulated
approximately 50%, 30% and 15% faster in the pole plasm
than in the neighbouring ooplasm of the three oocytes
examined, respectively. Taken together, these results
show that injected osk RNA accumulates at the posterior
pole while ooplasmic streaming proceeds.
Depolymerization of microtubules inhibits long-range
movement of injected osk RNA but does not prevent
posterior localization
To determine whether the polarized microtubule
network, characteristic of stage 7–10a oocytes, is required
for the localization of injected osk RNA, we injected the
RNA in the center of stage 9 oocytes in the presence of
colchicine, a microtubule-depolymerizing drug. Approxi-
mately 2–3 hours later, the majority of injected osk RNA
remained at the injection site, forming a local gradient
(Fig. 5a). However, a significant proportion of the RNA
had localized to both the anterior and the posterior poles
(Fig. 5a; compare with Fig. 1f), and the percentage of
oocytes in which injected RNA was localized was similar
in the presence and in the absence of the drug (Fig. 5g).
This suggests that, in stage 9 oocytes, the translocation of
injected osk RNA from the center of the oocyte to the
anterior and posterior poles, and the accumulation of the
RNA at these two locations, can occur in the absence of
microtubules. In the presence of the microtubules,
however, the dispersion of osk RNA within the ooplasm of
stage 9 oocytes is more efficient.
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Table 1
Mutations that prevent the localization of endogenous osk
RNA prevent the localization of injected osk RNA.
Oocyte genotype Localization of injected osk RNA
S10–11 oocytes injected Posterior localization
at the anterior
Wild-type 36% (101/279)
capu 0% (0/55)
spir 0% (0/58)
TmII 0% (0/192)
stau 0% (0/118)
osk54 0% (0/203)
S9 oocytes injected Anterior Posterior
in the center localization localization
Wild-type 37% (14/38)
TmII 24% (7/29)
Wild-type 46% (34/74)
osk54 0% (0/69)
osk RNA (3′ UTR) was injected at the anterior of wild-type, capu, spir,
TmII, stau and osk54 oocytes at stages 10 and 11 or in the center of
wild-type, TmII and osk54 oocytes at stage 9. Anterior localization and
posterior localization indicates the percentage of oocytes with
anteriorly or posteriorly localized RNA, respectively; numbers in
parentheses indicate the number of oocytes in which injected osk RNA
localized and the total number of oocytes analyzed. These data are
combined from 2–6 experiments for each genotype.
In stage 10b and 11 oocytes, microtubules are organized
into subcortical bundles without apparent anteroposterior
polarity [13]. These subcortical microtubules are thought
to be involved in generating ooplasmic streaming because
the streaming is sensitive to colchicine [32–34]. To
determine whether the subcortical microtubules were
required for the localization of injected osk RNA, we
coinjected the RNA with colchicine. In the presence of
colchicine, osk RNA injected at the anterior of stage
10b–11 oocytes dispersed only over a short distance
within the ooplasm (Fig. 5b); the range of this dispersion
was similar to the range observed in colchicine-injected
stage 9 oocytes (Fig. 5a). Injected RNA was not detected
at the posterior pole, however, indicating that micro-
tubules are required for the translocation of osk RNA
from the anterior to the posterior pole of stage 10b–11
oocytes.
The observation that colchicine treatment does not
prevent localization of injected osk RNA in stage 9
oocytes, which measure 45–130 mm in length [35], but
does prevent localization of the RNA in stage 10–11
oocytes, which measure 110–400 mm in length, suggests
that microtubules are required for long-range, but not
short-range translocation of the RNA. If this were true,
one would expect that decreasing the distance between
the site of injection and the posterior pole would facilitate
localization. Indeed, approximately twice as many oocytes
localized the RNA when it was injected in the center of
stage 10–11 oocytes than when it was injected at the ante-
rior (Fig. 5g). Moreover, even in the presence of
colchicine, osk RNA was localized in a significant fraction
of stage 10 and 11 oocytes injected in the center (Fig. 5g).
When the RNA was coinjected with colchicine within
50 mm of the posterior pole, it was localized in the major-
ity of oocytes, just as it was in the absence of the drug
(Fig. 5b,g). These results confirm that, in oocytes at stages
10 and 11, long-range translocation of osk RNA is micro-
tubule-dependent, but that short-range translocation can
occur in the presence of colchicine.
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Figure 4
Injected osk RNA accumulates in the pole
plasm as ooplasmic streaming proceeds.
Oocytes were injected with fluorescently
labelled osk RNA (3′ UTR), incubated for
1–2 h in the dark, then observed for the onset
of posterior accumulation. Subsequently, the
distribution of fluorescent RNA was recorded
by time-lapse microscopy with a digital
imaging system. (a) Three oocytes are shown,
all of which displayed ooplasmic streaming
concurrent with osk RNA localization. The first
and the last image from each series are
shown. Scale bar, 100 mm. (b) Quantitation of
the time-dependent increase in fluorescence
in the pole plasm as compared with the
neighbouring ooplasm (background). The
intensity differences between the pole plasm
and the neighbouring ooplasm are plotted on
the right axes. For further details, see
Materials and methods. The intensity values
are arbitrary.
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We used two criteria to determine whether microtubules
were depolymerized in oocytes in which injected osk RNA
localized in the presence of colchicine. First, eight
colchicine-treated oocytes, in which posteriorly injected
osk RNA had localized, were examined for the occurrence
of ooplasmic streaming; in all cases, the colchicine treat-
ment had effectively arrested the streaming, suggesting
that microtubule-dependent ooplasmic streaming is not
required to promote short-range osk RNA movement.
Second, to rule out the possibility that injected osk RNA
had localized before the coinjected colchicine caused
microtubule depolymerization, we injected the RNA into
oocytes dissected from flies that had been fed colchicine
for 6 hours; this drug treatment causes depolymerization
of microtubules in oocytes but does not affect localization
of endogenous osk RNA [15,16]. We confirmed by
immunostaining that, in such oocytes, microtubules were
depolymerized at the time of injection (Fig. 5f). When osk
RNA was injected in the center or close to the posterior
pole of oocytes dissected from colchicine-fed flies, the
RNA localized to the posterior pole (Fig. 5d,g). Thus, in
oocytes at stages 10 and 11, as in oocytes at stage 9,
accumulation of the injected osk RNA at the posterior pole
does not require microtubules.
We also tested whether actin microfilaments are required
for the localization of osk RNA by injecting the RNA in
the presence of drugs that prevent polymerization of these
cytoskeletal components. We found that, whether in the
presence or absence of cytochalasin D, injected osk RNA
localized to the posterior pole in a similar percentage of
oocytes (Fig. 5g), suggesting that cytochalasin-sensitive
actin filaments are not required for localization.
Hence, accumulation of injected osk RNA at the posterior
pole of stage 9, 10 and 11 oocytes is not sensitive to drugs
that depolymerize microtubules or actin filaments.
However, translocation of the RNA throughout the
ooplasm is less efficient in the presence of colchicine,
indicating that intact microtubules are required for the
long-range transport of the RNA.
Discussion
Transport of osk RNA by cytoplasmic flows
Several mechanisms could underlie the movement of
RNAs within cells, including simple diffusion, directed
transport, and transport by cytoplasmic flows [36].
Although the role of directed transport by molecular
motors has been discussed most frequently [1–3], the only
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Figure 5
Effects of depolymerization of microtubules and
actin filaments on the distribution of injected
osk RNA. Oocytes were coinjected with
fluorescently labelled osk RNA (3′ UTR) and
colchicine or cytochalasin D, to depolymerize
microtubules or actin filaments, respectively.
(a–c) In the presence of colchicine, injected
RNA disperses a short distance around the
injection site. (a,c) When the distance between
the injection site and the posterior pole is less
than 50 mm, the RNA accumulates at the
posterior pole. (b) When the distance between
the injection site and the posterior pole is more
than 50–100 mm, the RNA does not
accumulate at the posterior pole. (d–f)
Oocytes were dissected from flies fed
colchicine for 6 h. (d) Posteriorly injected osk
RNA disperses a short distance around the
injection site and localizes to the posterior pole.
Colchicine was coinjected with the RNA to
prevent repolymerization of the microtubule
network. Prior to the injections, microtubules
are depolymerized in egg chambers dissected
from flies fed colchicine (f) but not in control
egg chambers (e). The images of injected
oocytes were acquired 1.5–3 h after injection.
(g) Summary of the effects of colchicine,
cytochalasin D, and the site of injection on
localization of injected osk RNA. ‘Colchicine*’
indicates oocytes dissected from flies fed
colchicine for 6 h and subsequently injected
with osk RNA. ‘Posterior localization’ is defined
as in Table 1. These data are combined from
2–6 experiments per type of injection. S, stage;
scale bar, 100 mm.
(a)
(e)
(g)
(f)
S9-center (b) S10-anterior (c) S11-posterior (d) S10-posterior
Stage Site of injection Drug Posterior localization (%)
10/11 Anterior – 34% (127/379)
Colchicine 0% (0/28)
Cytochalasin D 39% (17/44)
10/11 Center – 60% (78/131)
Colchicine 18% (21/115)
Colchicine* 26% (5/19)
10/11 Posterior – 72% (68/95)
Colchicine 75% (24/32)
Colchicine* 61% (11/18)
9 Center – 51% (25/49)
Colchicine 48% (10/21)
direct evidence for the involvement of this mechanism
comes from the finding that myelin basic protein RNA
injected into oligodendrocytes moves in the cell processes
in anterograde fashion at 12 mm min–1 [37]. This move-
ment is kinesin-dependent, suggesting that the RNA
moves along microtubules [38]. As similar direct observa-
tions of RNA localization have not yet been reported in
other cell types, it is premature to conclude that directed
transport is a general mechanism of RNA localization.
Directed transport by microtubule-dependent motors has
also been proposed to account for the localization of
several RNAs to discrete sites within the Drosophila
oocyte (reviewed in [2,3,11,39,40]). This working model
is based on the observation that bcd and osk RNAs are
localized to the anterior and the posterior poles of the
oocyte, respectively, during stages 7–9 — when the
oocyte contains an anteroposteriorly polarized gradient of
microtubules [13]. The findings that a kinesin-b-
galactosidase (kin-b-gal) fusion protein localizes during
stages 8 and 9 to the posterior pole of the oocyte [15], that
inhibitors of microtubule polymerization affect the local-
ization of both kin-b-gal and bcd and osk RNAs
[14–16,41], and that injected bcd RNA associates with
astral microtubules in blastoderm embryos [42], have
further supported this model. However, direct evidence
for motor-based transport of RNA in Drosophila oocytes
has been lacking.
Here, we have begun to investigate how osk RNA localizes
within the Drosophila oocyte by observing the fate of
injected RNA. We find that injected osk RNA localizes in
oocytes at stages 9, 10 and 11. The simple observation that
osk RNA can localize in oocytes at each of these stages is
revealing. In particular, these results provide the first evi-
dence that osk RNA can localize during stages 10b and 11.
Previous analysis of the steady-state distribution of
endogenous osk RNA has indicated that a significant
portion of the RNA is localized by stage 10a, but technical
limitations precluded analysis of later stages [5,6]. Using
time-lapse microscopy, we have shown that injected osk
RNA localizes in oocytes at stages 10b and 11. In these
oocytes, injected osk RNA disperses in concentric circular
waves that parallel those of ooplasmic streaming of the
yolk, and this dispersion enables the RNA to reach the
posterior pole where it accumulates. Treatment with
colchicine to depolymerize microtubules reduces the
extent of dispersion of injected RNA. As ooplasmic
streaming ceases in the presence of colchicine, it is likely
that the inhibition of RNA dispersion by microtubule
drugs is a consequence of the drug-induced inhibition of
ooplasmic streaming. Hence, these experiments reveal
that transport by cytoplasmic flows could contribute to the
localization of endogenous osk RNA during oogenesis.
This mechanism could be used to promote the localization
of any endogenous osk RNA that enters the oocyte when
the nurse cells contract and ‘dump’ their cytoplasm into
the oocyte during stages 10b–12 [25,43].
The localization of injected osk RNA during stages 10b
and 11 is revealing for a second reason. The onset of
ooplasmic streaming correlates with a rearrangement of
the microtubule cytoskeleton within the oocyte. The
anteroposterior gradient of microtubules characteristic of
stages 7–10a disassembles during stage 10a, and a cortical
array of microtubules that lacks obvious polarity assembles
and persists during stages 10b-12. Thus, the localization of
injected osk RNA in stage 10b and 11 oocytes indicates
that injected osk RNA can localize in the absence of the
anteroposteriorly polarized microtubules.
Although a portion of endogenous osk RNA may localize
after the anteroposteriorly polarized microtubules have
disassembled, a significant fraction of the RNA localizes
during stages 7–10a. Earlier experiments suggested that the
polarized microtubule network present during these stages
participates in osk RNA localization [15,16]. In those experi-
ments, flies were fed colchicine to depolymerize micro-
tubules, and the distribution of microtubules, kin-b-gal and
osk RNA was examined after drug treatments of different
lengths. Colchicine treatment for 3.5 hours did not affect
endogenous osk RNA localization, although it was sufficient
to depolymerize microtubules and to abolish posterior accu-
mulation of kin-b-gal. Prolonged exposure to colchicine,
lasting 10–16 hours, was found to abolish osk RNA localiza-
tion in stage 8 and 9 oocytes, but not in oocytes of stage 10
or later. One interpretation of these results is that the drug
did not interfere with the maintenance of previously local-
ized RNA, but did interfere with microtubule-dependent
directed transport of the RNA. However, we have shown
here that colchicine treatment does not prevent localization
of injected osk RNA in stage 9 oocytes. It is therefore possi-
ble that endogenous osk RNA localizes in stage 9 oocytes by
a mechanism distinct from microtubule-dependent direc-
tional transport. Prolonged treatment with colchicine may
prevent posterior accumulation of osk RNA by interfering
with an early step in the localization process: establishment
of an anchor for osk RNA.
Our observation that the dispersion of injected osk RNA is
severely affected in stage 9 oocytes whose microtubules
have been disrupted indicates that a microtubule-depen-
dent process is essential for efficient dispersion of the
RNA. Our data do not allow us to determine the mecha-
nism of dispersion. One possibility is that efficient disper-
sion relies on directional transport of the RNA. An
alternative possibility is that osk RNA dispersion is medi-
ated by microtubule-dependent cytoplasmic flows, as we
have shown to be the case during later stages of oogenesis.
Time-resolved recordings of particle movements in
ooplasm indicate that microtubule-dependent cytoplasmic
flows are present from stage 6 through 12 [32,34,44].
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Further studies will be directed towards improving the
conditions for direct observation of osk RNA localization at
stage 9 to evaluate whether cytoplasmic flows or other
mechanisms, including directional transport, mediate osk
RNA localization.
Accumulation of osk RNA by binding to a localized anchor
Genetic evidence indicates that there are two distinct
aspects to osk RNA accumulation at the posterior pole:
initial localization of the RNA, and maintenance of the
localization. In osk mutants in which OSK protein is not
produced [9,10], osk RNA is localized transiently to the
posterior pole, indicating that the initial localization of the
RNA is independent of OSK [5,6]. The transient localiza-
tion disappears at stage 10, concurrent with the onset of
ooplasmic streaming, indicating that the maintenance of
osk RNA at the posterior pole requires OSK. As the local-
ization of injected osk RNA requires OSK, our assay
reveals the later stages of localization of osk RNA and its
maintenance. Moreover, our results suggest that OSK
plays a role not only in the maintenance of the localized
RNA but also in the continuous localization of osk RNA
after stages 8/9. OSK-dependent localization of osk RNA
correlates in time with the formation of polar granules,
RNA–protein complexes that are associated with
induction of the germ line [45,46]. Polar granules initially
appear at the posterior pole of the oocyte during stage 9,
and they persist past the end of oogenesis [20]. At the pos-
terior pole of stage 10 and 11 oocytes, we observe that
injected osk RNA colocalizes with GFP–VAS in particulate
structures. As VAS and OSK have been immunolocalized
to polar granules [21,22], it seems likely that osk RNA is
also a component of polar granules. Assembly of osk RNA
into polar granules may ensure the maintenance of the
RNA at the posterior pole.
RNA localization cannot be achieved solely by cytoplasmic
flows. In order for localization to occur, the RNA must be
selectively anchored. Our observation that injected osk
RNA localizes concurrently with ooplasmic streaming
demonstrates that the posteriorly localized anchor binds
and retains osk RNA in the presence of the entropic forces
that participate in RNA transport. Thus, our findings reveal
that the anchor plays a crucial role not only in the mainte-
nance of localized osk RNA, but also in the localization per
se. If osk RNA were localized by directional transport, its
accumulation at the posterior pole could be explained as the
result of continuous transport, analogous to the accumula-
tion of kin-b-gal observed at the posterior pole of stage 8/9
oocytes. However, as cytoplasmic flows occur in the oocyte
cytoplasm during most of oogenesis, it seems likely that
localization of osk RNA requires an anchor regardless of the
transport mechanism. Although the function of the osk
RNA anchor is microtubule-independent, microtubules
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Figure 6
A model of osk RNA localization during
oogenesis in Drosophila. osk RNA is
synthesized in the nurse cells and is then
localized to the oocyte. (a) In early oogenesis,
the RNA is transported into the oocyte, where
it accumulates; this transport process remains
uncharacterized and may involve directional
transport along microtubules that extend from
the oocyte into the nurse cells. During these
stages, an osk RNA anchor is established at
the posterior pole by a mechanism that may
involve microtubules and actin filaments. (b)
During mid-oogenesis, osk RNA becomes
redistributed within the oocyte: the RNA
accumulates transiently at the anterior and
begins to concentrate at the posterior pole,
where it binds to the localized anchor. Both
microtubule-dependent cytoplasmic flows and
microtubule-dependent directional transport
could participate in the redistribution of the
RNA. The transient anterior accumulation may
reflect binding sites that compete with the
posterior anchor for the binding of osk RNA.
At the posterior pole, localized osk RNA
induces the formation of polar granules. OSK
protein, translated at the posterior pole,
stabilizes the anchoring of osk RNA to the
polar granules and participates in the
continuous localization of the RNA. (c) During
late oogenesis, the remaining osk RNA is
transferred into the oocyte from the nurse
cells with the bulk flow of the nurse-cell
cytoplasm (‘nurse cell dumping’). The RNA is
dispersed in the ooplasm by ooplasmic
streaming. Upon reaching the posterior pole,
osk RNA continues to accumulate by binding
to the localized posterior anchor.
osk RNA
Direction of movement
Posterior anchor
OSK protein
Microtubule
Actin
Cytoplasmic flow
Early oogenesis
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may play a role in its establishment. If establishment of
the anchor occurs before stage 8, this could explain why
extended treatment with colchicine is required to abolish
the localization of endogenous osk RNA in stage 8/9
oocytes.
An actin-binding protein, TmII, whose RNA is posteriorly
localized in the oocyte [18], has been shown recently to be
required for posterior localization of osk RNA. These data
suggest that actin filaments may also participate in osk
RNA anchoring. The observation that injected osk RNA
localizes in the vicinity of the actin-rich oocyte cortex sup-
ports this possibility. However, depolymerization of actin
filaments with cytochalasins does not inhibit localization
of injected and endogenous [16] osk RNAs. Therefore, if
an actin-based structure participates in osk RNA anchor-
ing, it must be relatively stable. As tropomyosins are
known to stabilize actin filaments [47], it is conceivable
that TmII promotes formation of a cytochalasin-resistant
actin network to which osk RNA is anchored.
In stages 8/9, osk RNA is transiently enriched at the
anterior end of the oocyte. Our injection assay detects this
anterior accumulation of osk RNA at the appropriate
developmental stage, stage 9. Other RNAs, including
Bicaudal D, K10, orb and gurken (grk), also accumulate tran-
siently at the anterior of the oocyte during stages 8–9
[48–52], suggesting that all these RNAs bind to anteriorly
localized binding sites. Several mutations, including stau
and TmII, which disrupt posterior localization of osk RNA,
enhance anterior accumulation of the RNA. If the poste-
rior osk RNA anchor were to bind osk RNA more avidly
than the anteriorly localized binding sites, the RNA would
become progressively enriched at the posterior pole over
time. If mutations prevented the assembly of the posterior
anchor, this competition would not occur and osk RNA
would accumulate at the anterior pole.
Conclusions
We have shown that bulk cytoplasmic flows could
contribute to the localization of osk RNA (Fig. 6). This does
not exclude the possibility that directed transport also plays
a role at specific developmental stages. Transport by cyto-
plasmic flows and concentration by a specific, localized
anchor is a simple mechanism that could generate discrete
distribution patterns of RNA within a cell. During late
stages of oogenesis, after the onset of ooplasmic streaming,
nanos, germ cell-less and cyclin B RNAs localize to the poste-
rior pole of the Drosophila oocyte [53–55]. This cytoplasmic
flow is likely to translocate RNAs towards the pole plasm,
where they are anchored. It is also possible that cytoplasmic
flows contribute to the anterior localization of bcd RNA and
the anterodorsal localization of grk RNA [52] in Drosophila
oocytes. Continued analysis of the mechanisms of RNA
localization in Drosophila and other cell types will further
our understanding of intracellular organization.
Materials and methods
Fly strains and reagents
The following allelic combinations were used for RNA injections: Oregon
R (wild-type), spirRP/spirRP, capuRK/capuRK [31], stauD3/stauD3 [56],
Tm2gs1/Tm2gs1 [17], osk54/osk54 [5] and GFP–VAS [22]. RNAs were
transcribed from the following plasmids: pBlueosk [5] for full-length osk
and the coding region alone; osk DraI–NotI fragment in pBSIIKS
(nucleotide positions 3183–3309 of osk cDNA in [5]; NotI is the 3′
cloning site); the Drosophila rp49 cDNA [17]; the sea urchin cyclin B
coding region cDNA flanked by 5′ and 3′ UTRs of the Xenopus b-globin
[57]; and full-length bcd cDNA [27]. osk 3′ UTR (nucleotides
3156–3309), osk StyI–DraI fragment (nucleotides 3156–3183) and bcd
3′ UTR in pBSIISK+ (nucleotide positions 3978–4837 of bcd cDNA in
[27]) were provided by L.C. Olsen (L.C. Olsen and A. Ephrussi, unpub-
lished).
In vitro transcription and fluorescent labeling of the RNA
RNA for microinjection and for in situ hybridization was transcribed in
vitro. Typically, 5–10 mg of DNA was linearized, phenol:chloroform
extracted and ethanol precipitated using NH4OAc. Transcription compo-
nents were assembled at room temperature and included: DNA, tran-
scription buffer (10×, Boehringer Mannheim), 14 mM (final) MgCl2,
2.5 mM ATP, 2.5 mM CTP, 0.25 mM GTP, 2.5 mM of a mixture of UTP
and aminoallyl-UTP (Sigma; aminoallyl-UTP:UTP ratio was typically 1:10
or 1:5), 1 mM 7mG(5′)ppp(5′)G cap analog (BioLabs), RNAsin (50 U;
Boehringer Mannheim) and RNA polymerase T3 or T7 (40 U; Boehringer
Mannheim) in a final volume of 100ml. The reaction was incubated at
room temperature for 10 min, then rGTP was added to a final concentra-
tion of 2.5 mM. After a further 1 h incubation at 37°C, 40 U of RNA poly-
merase were added and the reaction continued for 1 h at 37°C.
RNAse-free DNAse was added (40 U; Boehringer Mannheim) and the
reaction was incubated for 15 min at 37°C. The RNA was extracted
twice with phenol:chloroform and once with chloroform. Unincorporated
nucleotides were removed by gel filtration on a Sephadex G50 spin
column (Boehringer Mannheim). RNA was NH4OAc:ethanol precipitated,
resuspended in DEPC-treated H20 and its quality evaluated by agarose
gel electrophoresis. Up to 100 mg of RNA was obtained per reaction.
The RNA was labelled with either 5-(and-6)-carboxy-X-rhodamine, suc-
cinimidyl ester or 6-(fluorescein-5-(and-6)-carboxamido)hexanoic acid,
succinimidyl ester (SFX; Molecular Probes). The RNA-labeling protocol
was adapted from the protein-labeling protocol provided by Molecular
Probes. Fluorochromes were dissolved in dimethyl-formamide (Sigma) at
100 mM. The labeling reaction contained 25mg of RNA, 5 mM fluo-
rochrome, and 0.15 mM bicarbonate buffer (pH 9) in a final volume of
100 ml. The reaction was incubated at room temperature for 1–3 h. Unin-
corporated fluorochromes were removed by gel filtration on a Sephadex
G50 spin column. The RNA was NH4OAc:ethanol precipitated and
resuspended in DEPC-treated H20 at 1 mg ml–1. Spectrophotometric
analysis indicates that the RNA was labelled with 10–30 fluorochromes
per RNA molecule.
Fluorescent in situ hybridization
Whole-mount in situ hybridization was performed as previously
described [5] with some modifications. Fixed egg chambers were
washed four times with PBS and 0.1% Tween 20 (PBT) for 5 min,
digested with proteinase K (Boehringer Mannheim) at 50mg ml–1 for
45 min, washed twice with PBT for 5 min, post-fixed in 4% paraformalde-
hyde:PBS for 20 min and washed twice with PBT for 5 min; all at room
temperature. Egg chambers were transferred into MetOH:DMSO (9:1)
for 1 h at –20°C, washed three times with PBT for 5 min at room temper-
ature, rinsed in PBT:hybridization buffer (1:1) and prehybridized in
hybridization buffer (HB) for 1 h at 60°C. HB contains 50% formamide,
5 × SSC, 100 mg ml–1 tRNA, 50 mg ml–1 heparin, 0.1% Tween 20,
pH 4.5 (with citric acid). The buffer was exchanged with 100 ml of pre-
warmed HB and 1–5 ml of SFX-labelled full-length osk anti-sense RNA
probe and the hybridization was incubated overnight at 60°C. Egg
chambers were washed three times with prewarmed HB for 20 min at
60°C, once with prewarmed PBT:HB (1:1) for 20 min at 60oC, and
four times with PBT for 20 min at room temperature. Egg chambers
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were mounted in 87% glycerol, 10 mM Tris pH 8.5, 4% n-propyl gallate
(Sigma).
Injection assay
Injection chambers were prepared as follows: a hole of 1.8 cm in diam-
eter was cut in a plexiglass slide (7.5 cm × 2 cm × 2 mm) and a cover-
slip was attached with wax to seal the chamber at the bottom. The
chambers were filled with a few drops of Voltalef 10S oil (Atochem). 2-
day-old female flies were anaesthetized with CO2, placed under oil and
the ovaries were dissected out and split into ovarioles or individual egg
chambers [34]. The injections were performed on the stage of an
upright microscope using a Zeiss AIS microinjection system. osk RNA
was injected at concentrations ranging from 0.05–1.0 mg ml–1. Similar
percentages of oocytes were found to localize the RNA injected at
0.25–1.0 mg ml–1 (see also Fig. 5). Approximately half as many oocytes
localized the RNA at the lowest concentration (0.05 mg ml–1). In the
majority of experiments, therefore, RNAs were injected at 0.5 mg ml–1 in
DEPC-treated H20. The volume of the average S10 oocyte was esti-
mated to be approximately 4–5 nl and the injection volume was esti-
mated to be 10–100 pl. In experiments in which drugs were coinjected,
colchicine (Sigma) was dissolved in EtOH at 20 mg ml–1 and was
diluted to a final concentration (in the needle) 2 mg ml–1 and
400 mg ml–1. We estimate that this results in approximately 100 mM and
20 mM final concentration in the oocyte. Similar results were obtained at
both concentrations tested. Cytochalasin D (Sigma) was dissolved in
DMSO at 10 mg ml–1 and was injected at the final concentration in the
needle at 200 mg ml–1, 250 mg ml–1 and 500 mg ml–1. We estimate that
this gives approximately 10 mM, 12.5 mM and 25 mM concentration in
the oocyte. Similar results were obtained at all three concentrations
tested. Analogous concentrations of colchicine and cytochalasin D in
culture medium have been shown to depolymerize microtubules and
some actin filaments, respectively, in Drosophila oocytes ([14,16,41];
our unpublished observations). In experiments in which osk RNA was
coinjected with colchicine into oocytes dissected from flies fed with
colchicine, the flies were first starved for 6 h, then fed for 6 h with freshly
prepared yeast paste containing 100 mg ml–1 colchicine [14–16,41,58],
or with yeast paste without the drug. Subsequently, 7–8 flies from each
group were dissected and one ovary from each fly was used for injec-
tions whereas the second ovary was used for microtubule staining.
Microtubules were stained as follows: dissected ovaries were fixed for
15 min in MetOH/50 mM EGTA pH 7 (prechilled to –20°C), washed
twice for 15 min in PBT, extracted for 2 h in PBS/1% Triton-100. Anti-
a-tubulin antibody (clone DM1 a; Sigma) was used at 1:250 in PBT
overnight, followed by four 15 min washes in PBT. DTAF-conjugated
goat a-mouse secondary antibody (Jackson ImmunoResearch Labora-
tories) was used at 1:100 in PBT for 2 h, followed by four 15 min
washes in PBT. Ovaries were post-fixed in 4% paraformaldehyde
(Sigma) in PBS, quenched in 50 mM NH4Cl in PBS for 15 min,
washed with PBS. All steps were performed at room temperature.
Ovaries were mounted on glass slides in 87% glycerol, 10 mM Tris
pH 8.5, 4% n-propyl gallate. To compare the distribution of injected
osk RNA and filamentous actin, injected egg chambers were fixed and
stained with rhodamine-labelled phalloidin (Molecular Probes) accord-
ing to the protocol adapted from [59], with the following modifications.
The fixative was applied under the oil in the vicinity of the samples. Fixa-
tion was at room temperature for 10 min, and then the oil was removed
with heptane. This procedure immobilizes the egg chambers on the
surface of the coverslip. The egg chambers were washed with PBT,
incubated with labelled phalloidin (5 ml in 1 ml of PBT) for 10–30 min in
dark, followed by extensive washes with PBT. The cover slips were
mounted on glass slides in 87% glycerol, 10 mM Tris pH 8.5, 4% n-
propyl gallate.
Microscopy and image processing
Laser scanning microscopy was performed with the EMBL compact
confocal microscope mounted on a Zeiss Axiovert equipped with 25×
(0.8 NA) and 100× (1.3 NA) oil immersion lenses. The images were
processed using Adobe Photoshop software. Time-lapse analysis of
accumulation of injected RNA was performed with a Photometrics
cooled CCD camera mounted on a Zeiss Axiovert controlled by soft-
ware developed at the EMBL [60]. Movement of autofluorescent yolk
platelets was detected in the fluorescein channel [34]. To quantitate
the accumulation of fluorescence in the pole plasm and in the neigh-
bouring ooplasm, the images were acquired at equal time intervals
under conditions where the full dynamic range of fluorescence was
registered by the camera. 20, 40 and 100 images of the three
oocytes were analyzed in each time series, respectively. Areas of
comparable size were chosen in the pole plasm and in the neighbour-
ing ooplasm and the fluorescence was integrated in these regions
and plotted as a function of time. To calculate the difference between
accumulations of fluorescence in the pole plasm and in the neigh-
bouring ooplasm, the average values were subtracted, and plotted as
a function of time. Image analysis was performed on a Macintosh
computer using the public domain NIH Image program (developed at
the U.S. National Institutes of Health and available on the Internet at
http://rsb.info.nih.gov/nih-image/).
Supplementary material
A brief video clip, showing the accumulation of injected osk RNA at the
posterior pole as ooplasmic streaming proceeds, is published with this
paper on the internet.
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